News of a new phase 3 Study may bring hope to pleural mesothelioma patients across the world who have stopped responding to standard chemotherapy. Trizell Ltd. recently announced that is has opened a phase 3 study of their promising new gene therapy for pleural mesothelioma, TR002. The current first-line and only approved drug therapy option
The post Phase 3 Clinical Trial for Gene Therapy Recruiting Mesothelioma Patients appeared first on Mesothelioma Help Now.
from Mesothelioma Help Now http://bit.ly/2UFpfYB
via IFTTT
Phase 3 Clinical Trial for Gene Therapy Recruiting Mesothelioma Patients
![Phase 3 Clinical Trial for Gene Therapy Recruiting Mesothelioma Patients]()
Reviewed by Unknown
on
April 24, 2019
Rating:
No comments: